Gene · 8202
Papers3,524
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,524
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PPAR-γ Partial Agonists in Disease-Fate Decision with Special Reference to Cancer. | Cells | 2022 | 36291082 | PubTator, text mining | PubMed |
| Nrf2 Modulation in Breast Cancer. | Biomedicines | 2022 | 36289931 | PubTator, text mining | PubMed |
| Identification of distinct circulating microRNAs in acute ischemic stroke patients with type 2 diabetes mellitus. | Front Cardiovasc Med | 2022 | 36277770 | PubTator, text mining | PubMed |
| Targeting phase separation on enhancers induced by transcription factor complex formations as a new strategy for treating drug-resistant cancers. | Front Oncol | 2022 | 36263200 | PubTator, text mining | PubMed |
| SRC-3 deficiency prevents atherosclerosis development by decreasing endothelial ICAM-1 expression to attenuate macrophage recruitment. | Int J Biol Sci | 2022 | 36263184 | PubTator, text mining | PubMed |
| Prediction of protein-protein interaction sites in intrinsically disordered proteins. | Front Mol Biosci | 2022 | 36250006 | PubTator, text mining | PubMed |
| Sensitive image-based chromatin binding assays using inducible ERα to rapidly characterize estrogenic chemicals and mixtures. | iScience | 2022 | 36238893 | PubTator, text mining | PubMed |
| Protein Acetylation Going Viral: Implications in Antiviral Immunity and Viral Infection. | Int J Mol Sci | 2022 | 36232610 | PubTator, text mining | PubMed |
| Epigenetic factors in breast cancer therapy. | Front Genet | 2022 | 36212140 | PubTator, text mining | PubMed |
| Combinatorial treatments of tamoxifen and SM6Met, an extract from Cyclopia subternata Vogel, are superior to either treatment alone in MCF-7 cells. | Front Pharmacol | 2022 | 36210845 | PubTator, text mining | PubMed |
| Hypoxia induces chemoresistance to proteasome inhibitors through orchestrating deSUMOylation and ubiquitination of SRC-3 in multiple myeloma. | Oncogene | 2022 | 36209257 | PubTator, text mining | PubMed |
| RNA export through the nuclear pore complex is directional. | Nat Commun | 2022 | 36202822 | PubTator, text mining | PubMed |
| Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus. | BMC Biol | 2022 | 36199058 | PubTator, text mining | PubMed |
| Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond. | Front Pharmacol | 2022 | 36188615 | PubTator, text mining | PubMed |
| Chaperone-assisted E3 ligase CHIP: A double agent in cancer. | Genes Dis | 2022 | 36157498 | PubTator, text mining | PubMed |
| Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models. | Breast Cancer Res | 2022 | 36153537 | PubTator, text mining | PubMed |
| Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: a review. | Discov Oncol | 2022 | 36152065 | PubTator, text mining | PubMed |
| Iron Metabolism in the Disorders of Heme Biosynthesis. | Metabolites | 2022 | 36144223 | PubTator, text mining | PubMed |
| Nuclear Receptor Pathways Mediating the Development of Boar Taint. | Metabolites | 2022 | 36144190 | PubTator, text mining | PubMed |
| Protein Profiling of Breast Carcinomas Reveals Expression of Immune-Suppressive Factors and Signatures Relevant for Patient Outcome. | Cancers (Basel) | 2022 | 36139700 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8202/papers?page=21